Indeed, overexpression of PLG-R including actin (ACT), enolase-1 (ENO-1), cytokeratin 8 (CK8) and annexin 2 (ANX2) has been associated with poor prognosis and resistance to chemotherapy of cancer patients. This evidence concerns the gene ENO1 and cancer.